Form 4: Baxter Executive Alok Sonig Sells Shares for Tax Withholding

Baxter International EVP Alok Sonig disposed of 3,191 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• Alok Sonig, EVP, Group President, Pharma at Baxter International Inc., reported a transaction on September 2, 2025.
• The transaction involved the disposition of 3,191 shares of common stock at a price of $24.17 per share.
• This disposition was a "forfeiture" (transaction code "F") specifically to cover tax withholding obligations.
• The taxes were incurred due to the delivery of shares from the settlement of restricted stock units (RSUs) that vested on September 2, 2025.
• These RSUs were originally granted on September 1, 2022.
• Following this transaction, Alok Sonig beneficially owns 128,219 shares of Baxter International common stock, which includes shares from automatic dividend reinvestment.

Sentiment

Score: 6

Explanation: The transaction is a routine tax-related disposition following RSU vesting, which is a neutral event. The underlying vesting is positive for the executive, but the disposition itself is not a direct 'buy' or 'sell' decision based on market sentiment.

Positives

• The underlying event is the vesting of restricted stock units, indicating compensation for the executive and a retention mechanism.
• The executive retains a significant beneficial ownership of 128,219 shares, demonstrating continued alignment with shareholder interests.

Negatives

• The disposition of shares, even for tax purposes, reduces the executive's direct shareholding.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction related to executive compensation, common across all industries for publicly traded companies. It does not reflect specific industry trends for healthcare or pharmaceuticals.

Comparison to Industry Standards

• This is a standard practice for executives receiving equity compensation. When restricted stock units vest, a portion of the shares is typically withheld or sold to cover the income tax liability, rather than the executive paying out-of-pocket.
• This mechanism is a common and expected method for managing equity compensation in public companies, ensuring tax compliance upon vesting without requiring the executive to use personal funds for the tax obligation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related transaction for executive compensation, not a discretionary sale. The executive retains a substantial holding.
• Employees: No direct impact on general employees.
• Management: The transaction reflects the vesting of equity compensation for a key executive, aligning their interests with the company's long-term performance.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related disposition of shares by an executive following the vesting of restricted stock units. Such transactions are standard practice for equity compensation and do not reflect a discretionary investment decision by the insider based on new material information. The executive retains a significant stake in the company. Therefore, this filing alone does not provide a basis for a change in investment recommendation; a 'hold' stance is appropriate as it's a neutral event.

Keywords

Baxter International, BAX, Alok Sonig, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Executive Compensation